BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma

BACKGROUND: Nonfunctioning pituitary adenoma (NFPA) and growth hormone pituitary adenoma (GHPA) are major subtypes of pituitary adenomas (PAs). The primary treatment is surgical resection. However, radical excision remains challenging, and few effective medical therapies are available. It is urgent...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Chengzhang, Ye, Zhao, Han, Jie, Ye, Xiaoqing, Lu, Wenchao, Ji, Chenxing, Li, Zizhou, Ma, Zengyi, Zhang, Qilin, Zhang, Yichao, He, Wenqiang, Chen, Zhengyuan, Cao, Xiaoyun, Shou, Xuefei, Zhou, Xiang, Wang, Yongfei, Zhang, Zhaoyun, Li, Yiming, Ye, Hongying, He, Min, Chen, Hong, Cheng, Haixia, Sun, Jun, Cai, Jianyong, Huang, Chuanxin, Ye, Fei, Luo, Cheng, Zhou, Bing, Ding, Hong, Zhao, Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Basic and Translational Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594556/
https://www.ncbi.nlm.nih.gov/pubmed/32246150
http://dx.doi.org/10.1093/neuonc/noaa084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594556/
https://www.ncbi.nlm.nih.gov/pubmed/32246150
http://dx.doi.org/10.1093/neuonc/noaa084

Ejemplares similares